| Structured Data | [
{
"@context": "https://schema.org/",
"@type": "LocalBusiness",
"name": "Proinvestor Play TV",
"url": "https://www.proinvestorplay.dk",
"address": {
"@type": "PostalAddress",
"addressCountry": "DK",
"addressLocality": "Holb\u00e6k",
"postalCode": 4300,
"streetAddress": "173 Ringstedvej"
},
"telephone": "+45 2855 6430"
},
{
"@context": "https://schema.org/",
"@type": "WebSite",
"name": "Proinvestor Play",
"url": "https://www.proinvestorplay.dk"
},
{
"@context": "https://schema.org",
"@type": "ItemList",
"itemListElement": [
{
"@type": "VideoObject",
"thumbnailUrl": "https://i.ytimg.com/vi/eJFlNB0zUgM/mqdefault.jpg",
"name": "Novo Nordisk, Gubra, Zealand Pharma",
"description": "Novo Nordisk har i den forgangne uge igen v\u00e6ret et af de helt store samtaleemner p\u00e5 Proinvestor.com. Denne gang er det en droppet aftale med Hims & Hers, der fik aktiekursen til atter at droppe. Efterfulgt af en nyhed, der fik kursen lidt tilbage p\u00e5 sporet, nemlig et samarbejde med Weight Watchers. S\u00e5 handler denne ugekommentar ogs\u00e5 om Gubra og udbytte, og om hvorvidt Zealand Pharma burde g\u00f8re det samme. Helge Larsen runder af med en ramt dansk life science-sektor - hvordan er udsigten til, at det vender?\n\nDenne video er ikke en anbefaling om k\u00f8b eller salg af aktier. Helge Larsen har aktier i de omtalte selskaber.\n\nF\u00e5 flere virksomhedsnyheder, markedskommentarer og analyser p\u00e5 Proinvestor.com's platforme: https://www.youtube.com/c/ProInvestorcom\nhttps://www.proinvestorplay.dk/\nhttps://www.facebook.com/groups/1552522675046712\nhttps://twitter.com/HelgeLarsen2\nhttps://www.linkedin.com/in/helge-larsen-34213417/ \nhttps://www.instagram.com/proinvestor.com.dk/\n\n00:00 Novo Nordisk og Hims & Hers\n02:41 Novo Nordisk og Weight Watchers\n06:08 Gubra\n06:55 Zealand Pharma\n07:54 Temperaturen p\u00e5 det globale aktiemarked og dansk life science",
"uploadDate": "2025-06-27T13:12:05Z",
"duration": "PT9M55S",
"embedUrl": "//www.youtube.com/embed/eJFlNB0zUgM",
"position": 1
},
{
"@type": "VideoObject",
"thumbnailUrl": "https://i.ytimg.com/vi/Zqnx3dLVYIY/mqdefault.jpg",
"name": "Novo Nordisk ADA 2025 - Fede data, tynd kursreaktion",
"description": "Novo Nordisk har i weekenden fremlagt rigtig gode data inden for fedme og v\u00e6gttabsmedicin p\u00e5 American Diabetes Association-konference i Chicago. Desv\u00e6rre er det ikke noget, der afspejler sig i aktiekursen - tv\u00e6rtimod. I denne special gennemg\u00e5r Helge Larsen hovedpunkterne fra de data, Novo fremlagde, og giver et bud p\u00e5, hvorfor kursreaktionen er s\u00e5 tynd.\n\nDenne video er ikke en anbefaling om k\u00f8b eller salg af aktier. Helge Larsen har aktier i Novo Nordisk.\n\nF\u00e5 flere virksomhedsnyheder, markedskommentarer og analyser p\u00e5 Proinvestor.com's platforme: https://www.youtube.com/c/ProInvestorcom\nhttps://www.proinvestorplay.dk/\nhttps://www.facebook.com/groups/1552522675046712\nhttps://twitter.com/HelgeLarsen2\nhttps://www.linkedin.com/in/helge-larsen-34213417/ \nhttps://www.instagram.com/proinvestor.com.dk/",
"uploadDate": "2025-06-23T12:00:06Z",
"duration": "PT6M58S",
"embedUrl": "//www.youtube.com/embed/Zqnx3dLVYIY",
"position": 2
},
{
"@type": "VideoObject",
"thumbnailUrl": "https://i.ytimg.com/vi/PPxjBN5lY5U/mqdefault.jpg",
"name": "Kursdyk i Zealand Pharma-aktien",
"description": "Helge Larsen har i flere \u00e5r v\u00e6ret investor i Zealand Pharma, fordi han godt kan lide businesscasen. Det har ikke \u00e6ndret sig. Selskabet klarer sig flot med en sp\u00e6ndende pipeline og en utrolig god aftale med Roche. Alligevel ser det ikke for godt ud med aktiekursen, som har taget et ordentligt dyk. Det samme kan man sige om Novo Nordisk, hvor kursen siden 2024 er mere en halveret. Helge Larsen ser p\u00e5 \u00e5rsagerne, inkl. hvorfor Zealand Pharma ikke stiger p\u00e5 en god nyhed, som selskabet var ude med i aftes.\n\nHusk i \u00f8vrigt at f\u00f8lge med p\u00e5 Proinvestor.com henover weekenden, hvor der er American Diabetes Association-konference i Chicago og freml\u00e6gges en masse sp\u00e6ndende data fra bl.a. Novo Nordisk.\n\nDenne video er ikke en anbefaling om k\u00f8b eller salg af aktier. Helge Larsen har aktier i de omtalte selskaber.\n\nF\u00e5 flere virksomhedsnyheder, markedskommentarer og analyser p\u00e5 Proinvestor.com's platforme: https://www.youtube.com/c/ProInvestorcom\nhttps://www.proinvestorplay.dk/\nhttps://www.facebook.com/groups/1552522675046712\nhttps://twitter.com/HelgeLarsen2\nhttps://www.linkedin.com/in/helge-larsen-34213417/ \nhttps://www.instagram.com/proinvestor.com.dk/",
"uploadDate": "2025-06-19T12:23:54Z",
"duration": "PT10M59S",
"embedUrl": "//www.youtube.com/embed/PPxjBN5lY5U",
"position": 3
}
]
},
{
"@context": "https://schema.org",
"@type": "ItemList",
"itemListElement": [
{
"@type": "VideoObject",
"thumbnailUrl": "https://i.ytimg.com/vi/jQpEJVcJDXc/mqdefault.jpg",
"name": "Pila Pharma aktieemission - n\u00e6ste skridt mod fedmepille",
"description": "Det dansk-svenske biotekselskab Pila Pharma satser benh\u00e5rdt p\u00e5 en fedmepille baseret p\u00e5 en s\u00e5kaldt chili-receptor. Derfor gennemf\u00f8rer selskabet en aktieemission p\u00e5 20 mio. SEK og optioner, s\u00e5 de kan komme videre p\u00e5 rejsen med prekliniske studier. En emission, som ganske us\u00e6dvanligt er fuldst\u00e6ndig forh\u00e5ndsgaranteret. H\u00f8r mere i denne video, hvor Helge Larsen har CEO Gustav Gram i studiet, og l\u00e6s mere om emissionen her https://pilapharma.com/\n\nDisclaimer: Denne video er ikke en opfordring til k\u00f8b eller salg af aktier.",
"uploadDate": "2025-06-27T16:16:54Z",
"duration": "PT12M46S",
"embedUrl": "//www.youtube.com/embed/jQpEJVcJDXc",
"position": 1
},
{
"@type": "VideoObject",
"thumbnailUrl": "https://i.ytimg.com/vi/-iQAwjF6QYU/mqdefault.jpg",
"name": "STENOCARE Q1 2025",
"description": "Danske Stenocare, som s\u00e6lger medicinsk cannabisolie, gennemf\u00f8rte i januar i \u00e5r en stor strategisk forandring, s\u00e5 selskabet i dag er koncentreret om handel og innovation og ikke l\u00e6ngere f.eks. produktion. Det kan bl.a. afl\u00e6ses i Stenocares Q1-rapport, som er samtaleafs\u00e6ttet for Helge Larsen og Stenocares CEO Thomas Skovlund Schnegelsberg og CFO Peter Bugge Johansen.\n\nDisclaimer: Stenocare har betalt IR-samarbejde med Proinvestor.com. Denne video er ikke en anbefaling om k\u00f8b eller salg af aktier.\n\nF\u00e5 flere virksomhedsnyheder, markedskommentarer og analyser p\u00e5 Proinvestor.com's platforme: https://www.youtube.com/c/ProInvestorcom\nhttps://www.proinvestorplay.dk/\nhttps://www.facebook.com/groups/1552522675046712\nhttps://twitter.com/HelgeLarsen2\nhttps://www.linkedin.com/in/helge-larsen-34213417/ \nhttps://www.instagram.com/proinvestor.com.dk/",
"uploadDate": "2025-06-27T15:38:04Z",
"duration": "PT11M42S",
"embedUrl": "//www.youtube.com/embed/-iQAwjF6QYU",
"position": 2
}
]
},
{
"@context": "https://schema.org",
"@type": "ItemList",
"itemListElement": [
{
"@type": "VideoObject",
"thumbnailUrl": "https://i.ytimg.com/vi/KRVkuJEhkLs/mqdefault.jpg",
"name": "Ugevideo 14 6 25",
"description": "S\u00e5 er ugens video klar til jer. Den blev lidt lang i dag, men der er b\u00e5de Mellem\u00f8sten, oliepriser, handelskrig, inflation, demonstrationer, Landbrugskrise i USA, rentem\u00f8de, krise i Kina, krise i Japan osv. osv. at forholde sig til. Det er ikke en kedelig verden, vi lever i. \nHer har I i hvert fald mit take p\u00e5 verdenssituationen.",
"uploadDate": "2025-06-15T10:40:57Z",
"duration": "PT39M28S",
"embedUrl": "//www.youtube.com/embed/KRVkuJEhkLs",
"position": 1
},
{
"@type": "VideoObject",
"thumbnailUrl": "https://i.ytimg.com/vi/XYhQPFQarc8/mqdefault.jpg",
"name": "Nye features i MyStockScanner",
"description": "S\u00e5 er det igen tid til at introducere nye features i MyStockScanner-platformen. \nI videoen her fremviser vi b\u00e5de den nye forside, og s\u00e5 er det med stor gl\u00e6de at vi nu kan introducere vores helt egne MSS-indikatorer i Tradingview inde i platformen.",
"uploadDate": "2025-06-13T13:16:18Z",
"duration": "PT8M6S",
"embedUrl": "//www.youtube.com/embed/XYhQPFQarc8",
"position": 2
},
{
"@type": "VideoObject",
"thumbnailUrl": "https://i.ytimg.com/vi/FzDDoxmTjaA/mqdefault.jpg",
"name": "NFP tallene er elendige - medierne siger det modsatte",
"description": "Vi gennemg\u00e5r her de nye NFP-tal, der absolut ikke er s\u00e5 gode, som de ser ud p\u00e5 overfladen.\n\n\nhttps://www.mystockscanner.com/",
"uploadDate": "2025-06-06T14:12:40Z",
"duration": "PT9M51S",
"embedUrl": "//www.youtube.com/embed/FzDDoxmTjaA",
"position": 3
}
]
},
{
"@context": "https://schema.org",
"@type": "ItemList",
"itemListElement": [
{
"@type": "VideoObject",
"thumbnailUrl": "https://i.ytimg.com/vi/xEDbx4KbkxQ/mqdefault.jpg",
"name": "weekly update 13-4-22",
"description": "Here is our Bi-weekly update on all our stock and ETF models.",
"uploadDate": "2022-04-14T07:10:39Z",
"duration": "PT8M40S",
"embedUrl": "//www.youtube.com/embed/xEDbx4KbkxQ",
"position": 1
},
{
"@type": "VideoObject",
"thumbnailUrl": "https://i.ytimg.com/vi/k0Va2fRnIRA/mqdefault.jpg",
"name": "Your complete guide to factor based investing - Book review",
"description": "Hi investment-gurus, \nHere is another video in our book review series. This time is called:\n\"Your complete guide to factor based investing - Book review\" and here we are taking a look at a very interesting book showing us which factors we should for when setting up a rules based investment strategy.",
"uploadDate": "2022-03-31T14:33:04Z",
"duration": "PT14M27S",
"embedUrl": "//www.youtube.com/embed/k0Va2fRnIRA",
"position": 2
}
]
},
{
"@context": "https://schema.org",
"@type": "ItemList",
"itemListElement": [
{
"@type": "VideoObject",
"thumbnailUrl": "https://i.ytimg.com/vi/SqNvkwASO8I/mqdefault.jpg",
"name": "Investeringspodcasten 280: Mellem\u00f8sten if\u00f8lge Trump",
"description": "Hvordan p\u00e5virker den geopolitiske uro i Mellem\u00f8sten de globale aktiemarkeder? Ugens afsnit af Investeringspodcasten dykker ned i investorernes reaktioner og markedets udvikling.\n\nI dette afsnit f\u00e5r du ogs\u00e5:\n- Seneste nyt om Novo Nordisk: Ny data og afbrudt samarbejde\n- Indblik i Teslas robottaxi og hvad det kan betyde for aktien\n\nL\u00e6s Pers blog om Novo Nordisks nye data: https://www.nordnet.dk/blog/novo-nordisk-staerke-data-kan-vende-stemningen/ \n\n00:00 Intro\n00:47 Trump genskaber freden?\n06:47 Hvad sker der med Tesla?\n12:29 Fedmeaktier og told p\u00e5 medicin\n16:23 Hvorn\u00e5r kommer tolden?\n20:38 Novo Nordisk - ny data og afbrudt aftale",
"uploadDate": "2025-06-26T07:35:02Z",
"duration": "PT29M22S",
"embedUrl": "//www.youtube.com/embed/SqNvkwASO8I",
"position": 1
},
{
"@type": "VideoObject",
"thumbnailUrl": "https://i.ytimg.com/vi/p6UoDCamoPI/mqdefault.jpg",
"name": "Investeringspodcasten 279: Risikoen lige nu, Toldaftaler, Novo, Zealand, \u00d8rsted og Vestas",
"description": "Urolige tider p\u00e5 verdensplan g\u00f8r mange nerv\u00f8se, men hvor h\u00f8j er risikoen egentlig for investorerne? H\u00f8r ogs\u00e5 om den aktuelle nedtur i Zealand Pharma, Trumps effekt p\u00e5 \u00d8rsted og Vestas samt om de nye data, der er p\u00e5 vej fra Novo Nordisk i afsnit 279 af Investeringspodcasten. \n\n00:00 Intro\n00:50 Mellem\u00f8stlig risiko\n05:47 Toldaftaler\n09:44 Zealand Pharma i nedtur\n17:36 Er Trump d\u00e5rlig for \u00d8rsted og Vestas?\n21:09 Ny data fra Novo p\u00e5 vej",
"uploadDate": "2025-06-18T14:50:31Z",
"duration": "PT29M21S",
"embedUrl": "//www.youtube.com/embed/p6UoDCamoPI",
"position": 2
},
{
"@type": "VideoObject",
"thumbnailUrl": "https://i.ytimg.com/vi/ghzXZqkgLtc/mqdefault.jpg",
"name": "Investeringspodcasten 278: Novo stiger, Forsvarsaktier, Toldaftale, Tesla",
"description": "Novo Nordisk stiger \u2013 og det kan der v\u00e6re flere gode grunde til. Men hvordan st\u00e5r Novo ift. konkurrenten Eli Lilly? H\u00f8r ogs\u00e5 om status p\u00e5 forsvarsaktier, Tesla-aktien, og hvorvidt vi kan forvente en toldaftale, i afsnit 278 af Investeringspodcasten. \n\n00:00 Intro\n00:50 Der kommer en toldaftale\n07:14 Forsvarsaktier\n12:14 Tesla svinger\n15:38 Demant med stort k\u00f8b\n19:49 GN Store Nord\n21:09 Novo Nordisk og hedgefonden",
"uploadDate": "2025-06-11T17:44:25Z",
"duration": "PT28M29S",
"embedUrl": "//www.youtube.com/embed/ghzXZqkgLtc",
"position": 3
}
]
},
{
"@context": "https://schema.org",
"@type": "ItemList",
"itemListElement": [
{
"@type": "VideoObject",
"thumbnailUrl": "https://i.ytimg.com/vi/xNrAoYvlZNQ/mqdefault.jpg",
"name": "Joakim Hannisdahl | Shipping Stocks 2025, Investing Ideas, Oil Tankers, VLGC, Containers | Vonheim",
"description": "#shipping #investing #shippingstocks\n00:00 - Learnings So Far In 2025\n00:40 - Intro Of Joakim Hannisdahl\n04:45 - How To Become A Shipping Investor?\n10:10 - How To Overcome Losses\n18:20 - How To Short Shipping Stocks\n21:45 - Instruments To Trade In Shipping\n24:28 - Shipping Markets (Car Carriers And Containers)\n31:00 - Tankers And Crude Markets\n40:05 - Very Large Gas Carriers, and LPG/Ammonia\n49:00 - Gersemi Asset Management Ambition\n\nJoakim Hannisdahl is a shipping investor and the founder and CEO of Gersemi Asset Management. Tune in for a great conversation about investing, shipping, and what's to come ahead, in volatile and unpredictable markets. \n\nChristopher Vonheim is a Norwegian host focused on business, ocean industries, investing, and start-ups. I hope you enjoy this tailor made content, and help us make this channel the best way to consume ideas, models, and stories that can help fuel the next entrepreneurs, leaders and top performers.\n\nListen to Vonheim on Spotify: https://spoti.fi/3vKLfVR\nListen to Vonheim on Apple Podcasts: https://apple.co/39125Gb\n\nChristopher Vonheim on Twitter: https://twitter.com/ChrisVonheim\nChristopher Vonheim on Web: https://christophervonheim.com\n\nDisclaimer: All opinions expressed by Christopher Vonheim or his guests on this podcast are only their opinions and do not reflect the opinions of Vonheim. You should not treat any opinion expressed by Christopher Vonheim as a specific reason to invest or follow a particular strategy, but only as an expression of his opinion. This podcast is for informational purposes only.",
"uploadDate": "2025-06-02T17:27:09Z",
"duration": "PT51M28S",
"embedUrl": "//www.youtube.com/embed/xNrAoYvlZNQ",
"position": 1
},
{
"@type": "VideoObject",
"thumbnailUrl": "https://i.ytimg.com/vi/K4kH-JprjyI/mqdefault.jpg",
"name": "Constantin Baack | MPC Container Ships 2025, US Tariffs, Methanol, Container Markets, And Red Sea",
"description": "#containership #containers #shipping \n00:00 - Investing In Methanol, And NCL Vestland\n03:15 - How To Decarbonize Shipping, And Elkem Deal\n04:15 - Container Markets 2025, Investments And Sales\n06:50 - US Tarrifs, And How To Navigate Ahead\n09:45 - Understanding US Policies Ahead (Security First)\n11:00 - Germany In 2025 (Investments Ahead)\n13:25 - MPC Capital Investment Strategy (Offshore Service)\n14:40 - Key Principles For Good Leadership\n16:35 - How To Balance Offense Vs Defence\nConstantin Baack is the CEO of MPC Capital and MPC Container Ships, a leading player in a niche shipping segment in the container markets. We sat down in Haugesund to discuss the christening of the new vessel NCL Vestland, and how Constantin sees the shipping market ahead. \n\nLet us know what you think of the episode and share it with friends and network! \n \nChristopher Vonheim is a Norwegian host focused on business, ocean industries, investing, and start-ups. I hope you enjoy this tailor made content, and help us make this channel the best way to consume ideas, models, and stories that can help fuel the next entrepreneurs, leaders and top performers.\n\nListen to Vonheim on Spotify: https://spoti.fi/3vKLfVR\nListen to Vonheim on Apple Podcasts: https://apple.co/39125Gb\n\nChristopher Vonheim on Twitter: https://twitter.com/ChrisVonheim\nChristopher Vonheim on Web: https://christophervonheim.com\n\nDisclaimer: All opinions expressed by Christopher Vonheim or his guests on this podcast are only their opinions and do not reflect the opinions of Vonheim. You should not treat any opinion expressed by Christopher Vonheim as a specific reason to invest or follow a particular strategy, but only as an expression of his opinion. This podcast is for informational purposes only.",
"uploadDate": "2025-04-06T07:21:48Z",
"duration": "PT19M10S",
"embedUrl": "//www.youtube.com/embed/K4kH-JprjyI",
"position": 2
},
{
"@type": "VideoObject",
"thumbnailUrl": "https://i.ytimg.com/vi/VgtrLiOgfuI/mqdefault.jpg",
"name": "Eirik Haavaldsen: Shipping Stocks 2025, Containers, Ro-Ro, LNG, LPG, Dry Bulk, Tankers, Valuations",
"description": "#investing #sjipping #valuations \n00:00 - Learnings So Far In 2025\n07:28 - Container Markets\n12:25 - Car Carrier And Ro-Ro Markets\n19:23 - Gas Markets (LNG and LPG)\n22:27 - Golar LNG\n26:20 - LPG Ahead\n28:25 - John Fredriksen Golden Ocean Exit \n33:10 - Dry Bulk Markets Ahead\n40:05 - Tankers Markets And Crude Oil\n46:30 - How To Value A Shipping Company \n51:44 - Best Question To Ask Shipping CEOs?\n54:33 - How To Make A Career In Shipping And Finance?\n01:00:44 - Most Impressive Shipping CEOs And Companies?\n01:03:50 - List A Shipping Company In Oslo or New York?\n01:05:50 - Favorite Books From Eirik Haavaldsen (Fiction)\n\nEirik Haavaldsen is Head of Research at Pareto, and one of leading experts on shipping stocks. In this episode, we analyse all shipping segments for 2025, and learn how Eirik finds value in different types of maritime companies. Let us know what you think of the episode, and please comment and share the interview with friends and network. It helps more than you can imagine! \n \nChristopher Vonheim is a Norwegian host focused on business, ocean industries, investing, and start-ups. I hope you enjoy this tailor made content, and help us make this channel the best way to consume ideas, models, and stories that can help fuel the next entrepreneurs, leaders and top performers.\n\nListen to Vonheim on Spotify: https://spoti.fi/3vKLfVR\nListen to Vonheim on Apple Podcasts: https://apple.co/39125Gb\n\nChristopher Vonheim on Twitter: https://twitter.com/ChrisVonheim\nChristopher Vonheim on Web: https://christophervonheim.com\n\nDisclaimer: All opinions expressed by Christopher Vonheim or his guests on this podcast are only their opinions and do not reflect the opinions of Vonheim. You should not treat any opinion expressed by Christopher Vonheim as a specific reason to invest or follow a particular strategy, but only as an expression of his opinion. This podcast is for informational purposes only.",
"uploadDate": "2025-03-16T08:16:24Z",
"duration": "PT1H8M22S",
"embedUrl": "//www.youtube.com/embed/VgtrLiOgfuI",
"position": 3
}
]
}
] |